X
GILD icon

Xponance’s Gilead Sciences GILD Stock Holding History

Xponance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1M Sell
238,168
-28,763
-11% -$3.79M 0.18% 78
2026
Q1 		$37.2M Buy
266,931
+29,440
+12% +$4.12M 0.26% 58
2025
Q4 		$29.1M Buy
237,491
+12,516
+6% +$1.52M 0.22% 74
2025
Q3 		$25M Buy
224,975
+4,591
+2% +$522K 0.2% 78
2025
Q2 		$24.4M Sell
220,384
-1,576
-0.7% -$168K 0.2% 80
2025
Q1 		$24.9M Buy
221,960
+28,744
+15% +$2.97M 0.24% 65
2024
Q4 		$17.8M Sell
193,216
-736
-0.4% -$66.3K 0.16% 99
2024
Q3 		$16.3M Sell
193,952
-989
-0.5% -$75.5K 0.16% 104
2024
Q2 		$13.4M Sell
194,941
-1,000
-0.5% -$66.7K 0.14% 118
2024
Q1 		$14.4M Buy
195,941
+9,498
+5% +$730K 0.15% 118
2023
Q4 		$15.1M Buy
186,443
+13,667
+8% +$1.06M 0.18% 99
2023
Q3 		$12.9M Buy
172,776
+1,662
+1% +$128K 0.18% 94
2023
Q2 		$13.2M Sell
171,114
-1,241
-0.7% -$99K 0.18% 99
2023
Q1 		$14.3M Buy
172,355
+3,650
+2% +$302K 0.21% 90
2022
Q4 		$14.5M Buy
168,705
+19,312
+13% +$1.53M 0.23% 83
2022
Q3 		$9.22M Buy
149,393
+39,581
+36% +$2.5M 0.18% 109
2022
Q2 		$6.79M Buy
109,812
+19,081
+21% +$1.18M 0.14% 132
2022
Q1 		$5.39M Buy
90,731
+4,485
+5% +$287K 0.09% 187
2021
Q4 		$6.26M Buy
86,246
+19,343
+29% +$1.33M 0.1% 178
2021
Q3 		$4.67M Sell
66,903
-6,062
-8% -$426K 0.09% 190
2021
Q2 		$5.02M Sell
72,965
-36,147
-33% -$2.41M 0.09% 179
2021
Q1 		$7.05M Buy
109,112
+597
+0.6% +$38.5K 0.15% 127
2020
Q4 		$6.32M Buy
108,515
+953
+0.9% +$57.5K 0.14% 131
2020
Q3 		$6.8M Sell
107,562
-11,846
-10% -$821K 0.17% 111
2020
Q2 		$9.19M Buy
+119,408
New +$9.15M 0.24% 90

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Xponance's GILD Position: Q2 2026 in Review

Xponance reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $3.79M and leaving 238,168 shares worth $30.1M. The position accounts for 0.18% of the portfolio, ranked #78.

Xponance first reported a position in GILD in Q2 2020 and has held it in 25 quarters since. The position peaked at $37.2M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Xponance held 238,168 shares of Gilead Sciences worth $30.1M as of Q2 2026.
  • Xponance sold 28,763 Gilead Sciences shares in Q2 2026, an estimated $3.79M.
  • Gilead Sciences made up 0.18% of Xponance's portfolio in Q2 2026, its #78 holding.
  • Xponance first reported a position in Gilead Sciences in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Gilead Sciences position peaked at $37.2M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.